Steroid therapy is associated with decreased numbers of dendritic cells and fibroblasts, and increased numbers of satellite cells, in the dystrophic skeletal muscle

Journal of Clinical Pathology

Volumn 63, Issue 9, 2010, Pages 805-813

  Hussein, Mahmoud Rezk Abdelwahed ^a   Abu Dief, Eman E ^b   Kamel, Nageh Fouly ^c   Mostafa, Mohammed G ^a  

^a Assiut University   (Egypt)

^b Sohag University   (Egypt)

^c ASSIUT UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CELL COUNT; CHILD; CLINICAL ARTICLE; DENDRITIC CELL; DUCHENNE MUSCULAR DYSTROPHY; ENDOMYSIUM; FIBROBLAST; HETEROCHROMATIN; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE FIBRIL; MUSCLE MITOCHONDRION; MUSCULAR DYSTROPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SATELLITE CELL; SCHOOL CHILD; STEROID THERAPY; TRANSMISSION ELECTRON MICROSCOPY;

ADOLESCENT; BIOPSY; CELL COUNT; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; FIBROBLASTS; GLUCOCORTICOIDS; HUMANS; MALE; MICROSCOPY, ELECTRON; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOFIBRILS; PREDNISONE; RETROSPECTIVE STUDIES; SATELLITE CELLS, SKELETAL MUSCLE;

EID: 77956936240     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.078204     Document Type: Article

References (37)

1. Vannucchi MG, Corsani L, Faussone-Pellegrini MS. Synaptic vesicle morphology and recycling are altered in myenteric neurons of mice lacking dystrophin (mdx mice). J Cell Physiol 2003;197:232-42. (Pubitemid 37485252)
2. Selcen D, Engel AG. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004;62:1363-71.
3. Gilchrist JM, Ambler M, Agatiello P. Steroid-responsive tubular aggregate myopathy. Muscle Nerve 1991;14:233-6.
4. Esper JJ, Nigro MA, Wishnow R, et al. Clinical improvement of the myopathy in eosinophilia-myalgia syndrome with steroids and rehabilitative therapy. J Am Osteopath Assoc 1992;92:1056-8.
5. Balaban B, Matthews DJ, Clayton GH, et al. Corticosteroid treatment and functional improvement in duchenne muscular dystrophy: long-term effect. Am J Phys Med Rehabil 2005;84:843-50.
6. Beenakker EA, Fock JM, Van Tol MJ, et al. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial. Arch Neurol 2005;62:128-32.
7. Arpinati M, Chirumbolo G, Urbini B, et al. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2004;10:106-15.
8. Bobryshev YV, Watanabe T. Ultrastructural evidence for association of vascular dendritic cells with T-lymphocytes and with B-cells in human atherosclerosis. J Submicrosc Cytol Pathol 1997;29:209-21. (Pubitemid 127460146)
9. Maier F, Bornemann A. Comparison of the muscle fiber diameter and satellite cell frequency in human muscle biopsies. Muscle Nerve 1999;22:578-83.
10. Sebille A. [Cell therapy prospects in Duchenne muscular dystrophy] (In French). J Soc Biol 2005;199:13-16.
11. Hillier J, Jones GE, Statham HE, et al. Cell surface abnormality in clones of skin fibroblasts from a carrier of Duchenne muscular dystrophy. J Med Genet 1985;22:100-3. (Pubitemid 15103940)
12. Jung-Testas I, Baulieu EE. Anti-steroid action in cultured L-929 mouse fibroblasts. J Steroid Biochem 1984;20:301-6.
13. Hussein MR, Hamed SA, Mostafa MG, et al. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies. J Exp Pathol 2006;87:451-61.
14. Gulati S, Saxena A, Kumar V, et al. Duchenne muscular dystrophy: prevalence and patterns of cardiac involvement. Indian J Pediatr 2005;72:389-93. (Pubitemid 40839656)
15. Hussein MR, Hassan M, Wood GS. Morphological changes and apoptosis in radial growth phase melanoma cell lines following ultraviolet-B irradiation. Am J Dermatopathol 2003;25:466-72.
16. Hussein MR, Abu-Dief EE, Abd El-Reheem MH, et al. Ultrastructural evaluation of the radioprotective effects of melatonin against X-ray-induced skin damage in Albino rats. Int J Exp Pathol 2005;86:45-55.
17. Fisher ER, Cohn RE, Danowski TS. Ultrastructural observations of skeletal muscle in myopathy and neuropathy with special reference to muscular dystrophy. Lab Invest 1966;15:778-93.
18. Watkins SC, Cullen MJ. A quantitative study of myonuclear and satellite cell nuclear size in Duchenne's muscular dystrophy, polymyositis and normal human skeletal muscle. Anat Rec 1988;222:6-11.
19. Markham LW, Spicer RL, Khoury PR, et al. Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol 2005;26:768-71.
20. Takagi A, Watanabe T, Kojima S, et al. [Effect of long-term administration of prednisolone on serum creatine kinase and muscle pathology of mdx mouse] (In Japanese). Rinsho Shinkeigaku 1998;38:724-8.
21. Anderson JL, Head SI, Rae C, et al. Brain function in Duchenne muscular dystrophy. Brain 2002;125:4-13. (Pubitemid 34084032)
22. Gosselin LE, McCormick KM. Targeting the immune system to improve ventilatory function in muscular dystrophy. Med Sci Sports Exerc 2004;36:44-51.
23. Wehling-Henricks M, Lee JJ, Tidball JG. Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle. Neuromuscul Disord 2004;14:483-90.
24. Piemonti L, Monti P, Allavena P, et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999;162:6473-81.
25. Vanderheyde N, Verhasselt V, Goldman M, et al. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 1999;67:1342-7. (Pubitemid 29252410)
26. Matasic R, Dietz AB, Vuk-Pavlovic S. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol 1999;66:909-14.
27. Pan J, Ju D, Wang Q, et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett 2001;76:153-61.
28. Chen YW, Zhao P, Borup R, et al. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 2000;151:1321-36.
29. Zhang Z, Xu D, Li Y, et al. Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome. Clin Immunol 2005;116:225-35.
30. Dong X, Bachman LA, Kumar R, et al. Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transpl Immunol 2003;11:323-33. (Pubitemid 37120551)
31. Keenihan SN, Robertson SA. Diversity in phenotype and steroid hormone dependence in dendritic cells and macrophages in the mouse uterus. Biol Reprod 2004;70:1562-72.
32. Lim JH, Kim DY, Bang MS. Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse. Muscle Nerve 2004;30:456-62.
33. Armelin MC, Armelin HA. Steroid hormones mediate reversible phenotypic transition between transformed and untransformed states in mouse fibroblasts. Proc Natl Acad Sci U S A 1978;75:2805-9.
34. Breslow JL, Epstein J, Forbes GB, et al. Steroid hormone toxicity in human fibroblasts does not correlate with high affinity receptor content. J Cell Physiol 1979;99:343-8.
35. Dubaybo BA, Marwah GS, Rubeiz GJ. Steroid responsiveness of fibroblasts of paraquat injured lungs. Res Commun Chem Pathol Pharmacol 1991;71:365-80.
36. Desnuelle C, Sacconi S, Marolleau JP, et al. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy] (in French). Bull Acad Natl Med 2005;189:697-713; discussion 713-14.
37. Kadi F, Eriksson A, Holmner S, et al. Effects of anabolic steroids on the muscle cells of strength-trained athletes. Med Sci Sports Exerc 1999;31:1528-34.